The British Journal of Rheumatology, Vol 36, 1178-1183, Copyright © 1997 by British Society for Rheumatology
B Coll-Vinent, JM Grau, A Lopez-Soto, J Oristrell, C Font, X Bosch, E Mirapeix, A Urbano-Marquez and MC Cid
The objective was to evaluate whether changes in circulating soluble
adhesion molecule levels reflect disease activity in patients with systemic
polyarteritis nodosa (PAN). A sandwich ELISA was used to measure soluble
(s) intercellular adhesion molecule 1 (sICAM-1), vascular cell adhesion
molecule 1 (sVCAM-1), E-selectin, L-selectin and P-selectin in sera and
plasma from 22 patients with active PAN, in sera from 13 of these patients
taken serially during follow-up, and in sera from 13 healthy controls. At
the time of diagnosis, sICAM-1, sVCAM-1 and sE-selectin levels (488.5 +/-
201.3, 1176.5 +/- 514.1 and 60.6 +/- 27 ng/ml, respectively) were
significantly higher in patients than in controls (P < 0.0001, P = 0.001
and P = 0.003, respectively). In contrast, sL-selectin levels tended to be
lower in patients than in controls. Within the first 7 days after starting
treatment, there was a significant increase in sICAM-1 concentrations,
which fell thereafter, but did not completely reach normal levels when
patients achieved clinical remission. sE-selectin also remained elevated
during follow- up. Only sVCAM-1 decreased, tending to reach normal values
in inactive disease. Increased levels of sICAM-1, sVCAM-1 and sE-selectin,
and decreased levels of sL-selectin, in active PAN suggest immune and
endothelial stimulation during disease activity. Abnormal levels of soluble
adhesion molecules in clinically inactive patients might reflect
persistence of immune activation and/or endothelial cell exposure to a
remaining inflammatory microenvironment.
ORIGINAL PAPERS
Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa
Department of Internal Medicine, Hospital Clinic, Barcelona, Spain.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Cogalgil and S. Taysi Levels of Antioxidant Proteins and Soluble Intercellular Adhesion Molecule-1 in Serum of Patients with Rheumatoid Arthritis Ann. Clin. Lab. Sci., July 1, 2002; 32(3): 264 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Turesson, P. Englund, L. T. H. Jacobsson, G. Sturfelt, L. Truedsson, I. Nennesmo, and I. E. Lundberg Increased endothelial expression of HLA-DQ and interleukin 1{alpha} in extra-articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscle Rheumatology, December 1, 2001; 40(12): 1346 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ara, E. Mirapeix, P. Arrizabalaga, R. Rodriguez, C. Ascaso, R. Abellana, J. Font, and A. Darnell Circulating soluble adhesion molecules in ANCA-associated vasculitis Nephrol. Dial. Transplant., February 1, 2001; 16(2): 276 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Coll-Vinent, C. Vilardell, C. Font, J. Oristrell, J. Hernández-Rodríguez, J. Yagüe, A. Urbano-Márquez, J. M Grau, and M. C Cid Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity Ann Rheum Dis, March 1, 1999; 58(3): 189 - 192. [Abstract] [Full Text] |
||||



